Mark Kawakami's most recent trade in Arcadia Biosciences Inc was a trade of 12,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcadia Biosciences Inc | Mark Kawakami | Chief Financial Officer | 09 May 2025 | 12,500 | 33,987 | - | - | Stock Option (Right to Buy) | ||
| Arcadia Biosciences Inc | Mark Kawakami | Chief Financial Officer | 03 Feb 2025 | 700 | 2,681 (0%) | 0% | 2.5 | 1,743 | Common Stock | |
| Arcadia Biosciences Inc | Mark Kawakami | Chief Financial Officer | 19 Aug 2024 | 20,000 | 21,487 | - | - | Stock Option (Right to Buy) | ||
| Arcadia Biosciences Inc | Mark Kawakami | Chief Financial Officer | 01 Aug 2024 | 700 | 1,981 (0%) | 0% | 2.1 | 1,442 | Common Stock |